Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers.

Golmard L, Castéra L, Krieger S, Moncoutier V, Abidallah K, Tenreiro H, Laugé A, Tarabeux J, Millot GA, Nicolas A, Laé M, Abadie C, Berthet P, Polycarpe F, Frébourg T, Elan C, de Pauw A, Gauthier-Villars M, Buecher B, Stern MH, Stoppa-Lyonnet D, Vaur D, Houdayer C.

Eur J Hum Genet. 2017 Dec;25(12):1345-1353. doi: 10.1038/s41431-017-0021-2. Epub 2017 Nov 8.

2.

Germline mutation in the RAD51B gene confers predisposition to breast cancer.

Golmard L, Caux-Moncoutier V, Davy G, Al Ageeli E, Poirot B, Tirapo C, Michaux D, Barbaroux C, d'Enghien CD, Nicolas A, Castéra L, Sastre-Garau X, Stern MH, Houdayer C, Stoppa-Lyonnet D.

BMC Cancer. 2013 Oct 19;13:484. doi: 10.1186/1471-2407-13-484.

3.

Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.

Song H, Dicks E, Ramus SJ, Tyrer JP, Intermaggio MP, Hayward J, Edlund CK, Conti D, Harrington P, Fraser L, Philpott S, Anderson C, Rosenthal A, Gentry-Maharaj A, Bowtell DD, Alsop K, Cicek MS, Cunningham JM, Fridley BL, Alsop J, Jimenez-Linan M, Høgdall E, Høgdall CK, Jensen A, Kjaer SK, Lubiński J, Huzarski T, Jakubowska A, Gronwald J, Poblete S, Lele S, Sucheston-Campbell L, Moysich KB, Odunsi K, Goode EL, Menon U, Jacobs IJ, Gayther SA, Pharoah PD.

J Clin Oncol. 2015 Sep 10;33(26):2901-7. doi: 10.1200/JCO.2015.61.2408. Epub 2015 Aug 10.

4.

RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families.

Pelttari LM, Kiiski JI, Ranta S, Vilske S, Blomqvist C, Aittomäki K, Nevanlinna H.

Springerplus. 2015 Feb 24;4:92. doi: 10.1186/s40064-015-0880-3. eCollection 2015.

5.

Involvement of Rad51C in two distinct protein complexes of Rad51 paralogs in human cells.

Liu N, Schild D, Thelen MP, Thompson LH.

Nucleic Acids Res. 2002 Feb 15;30(4):1009-15.

6.

Interactions involving the Rad51 paralogs Rad51C and XRCC3 in human cells.

Wiese C, Collins DW, Albala JS, Thompson LH, Kronenberg A, Schild D.

Nucleic Acids Res. 2002 Feb 15;30(4):1001-8.

7.

Evidence for simultaneous protein interactions between human Rad51 paralogs.

Schild D, Lio YC, Collins DW, Tsomondo T, Chen DJ.

J Biol Chem. 2000 Jun 2;275(22):16443-9.

8.

The Arabidopsis RAD51 paralogs RAD51B, RAD51D and XRCC2 play partially redundant roles in somatic DNA repair and gene regulation.

Wang Y, Xiao R, Wang H, Cheng Z, Li W, Zhu G, Wang Y, Ma H.

New Phytol. 2014 Jan;201(1):292-304. doi: 10.1111/nph.12498. Epub 2013 Sep 18.

9.

RAD51 and breast cancer susceptibility: no evidence for rare variant association in the Breast Cancer Family Registry study.

Le Calvez-Kelm F, Oliver J, Damiola F, Forey N, Robinot N, Durand G, Voegele C, Vallée MP, Byrnes G, Registry BC, Hopper JL, Southey MC, Andrulis IL, John EM, Tavtigian SV, Lesueur F.

PLoS One. 2012;7(12):e52374. doi: 10.1371/journal.pone.0052374. Epub 2012 Dec 27.

10.

RAD51C interacts with RAD51B and is central to a larger protein complex in vivo exclusive of RAD51.

Miller KA, Yoshikawa DM, McConnell IR, Clark R, Schild D, Albala JS.

J Biol Chem. 2002 Mar 8;277(10):8406-11. Epub 2001 Dec 13.

11.

Functional characterization and identification of mouse Rad51d splice variants.

Gruver AM, Yard BD, McInnes C, Rajesh C, Pittman DL.

BMC Mol Biol. 2009 Mar 27;10:27. doi: 10.1186/1471-2199-10-27.

12.

Rice RAD51 paralogs play essential roles in somatic homologous recombination for DNA repair.

Xu Z, Zhang J, Xu M, Ji W, Yu M, Tao Y, Gong Z, Gu M, Yu H.

Plant J. 2018 Jul;95(2):282-295. doi: 10.1111/tpj.13949. Epub 2018 Jun 6.

13.

RAD-ical New Insights into RAD51 Regulation.

Sullivan MR, Bernstein KA.

Genes (Basel). 2018 Dec 13;9(12). pii: E629. doi: 10.3390/genes9120629. Review.

14.

The association between polymorphisms of the RAD51-G135C, XRCC2-Arg188His and XRCC3-Thr241Met genes and clinico-pathologic features in breast cancer in Poland.

Romanowicz-Makowska H, Smolarz B, Zadrozny M, Westfa B, Baszczyński J, Kokołaszwili G, Burzyfiski M, Połać I, Sporny S.

Eur J Gynaecol Oncol. 2012;33(2):145-50.

PMID:
22611952
15.

RAD51C germline mutations in breast and ovarian cancer cases from high-risk families.

Clague J, Wilhoite G, Adamson A, Bailis A, Weitzel JN, Neuhausen SL.

PLoS One. 2011;6(9):e25632. doi: 10.1371/journal.pone.0025632. Epub 2011 Sep 28.

16.

Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer.

Webb PM, Hopper JL, Newman B, Chen X, Kelemen L, Giles GG, Southey MC, Chenevix-Trench G, Spurdle AB.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):319-23.

17.

Correlation between selected XRCC2, XRCC3 and RAD51 gene polymorphisms and primary breast cancer in women in Pakistan.

Qureshi Z, Mahjabeen I, Baig R, Kayani M.

Asian Pac J Cancer Prev. 2014;15(23):10225-9.

18.

Interplay between human DNA repair proteins at a unique double-strand break in vivo.

Rodrigue A, Lafrance M, Gauthier MC, McDonald D, Hendzel M, West SC, Jasin M, Masson JY.

EMBO J. 2006 Jan 11;25(1):222-31. Epub 2006 Jan 5.

19.

Domain mapping of the Rad51 paralog protein complexes.

Miller KA, Sawicka D, Barsky D, Albala JS.

Nucleic Acids Res. 2004 Jan 2;32(1):169-78. Print 2004.

20.

Analysis of RAD51D in ovarian cancer patients and families with a history of ovarian or breast cancer.

Thompson ER, Rowley SM, Sawyer S, kConfab, Eccles DM, Trainer AH, Mitchell G, James PA, Campbell IG.

PLoS One. 2013;8(1):e54772. doi: 10.1371/journal.pone.0054772. Epub 2013 Jan 25.

Supplemental Content

Support Center